Abstract: The present disclosure related to a method of using high frequency sound waves directed toward an acoustically active particle. The high frequency sound waves may be configured to enlarge the acoustically active particle and oscillate the acoustically active particle, thereby facilitating extravasation of an agent to a tissue compartment of a region of interest.

Abstract: Disclosed herein are methods relating to manufacturing an embolizing agent precursor. Manufacture of the embolizing agent precursor may involve mixing a first component contained within a first container with a second component contained within a second container, the first component including a plurality of negatively charged gaseous components and a first stabilizer, the second component comprising a plurality of positively charged oil components, a second stabilizer, and a cationic surfactant. Further steps may include mixing the first component with the second component such that the first and second component are held together as a single agglomerated entity.

Abstract: Disclosed herein are compositions and methods for an embolizing agent precursor. The embolizing agent precursor may include a gaseous component and a first stabilizer to stabilize the gaseous component, the first stabilizer may include a a polymer, and wherein a gas portion of the gaseous component is selected from the group consisting of sulphur hexafluoride and C3-6 perfluorocarbons. The embolizing agent precursor may further include an oil component which comprises a C1-7 hydrocarbon, a second stabilizer to stabilize the oil component, and a vaporous component configured to enlarge the gaseous component.

Abstract: The present disclosure relates to a method of imaging, involving administration of a bi-phasic formulation followed by application of high frequency sound waves to identify a region of interest. Following identification, a phase shift of the bi-phasic formulation may be activated by a second administration of high frequency sound waves such that gaseous components of the bi-phasic formulation are enlarged and localised at the region of interest.

Abstract: The present invention relates to ultrasound mediated delivery of antimicrobial agents to sites of infection, and particularly for treatment of infections. Thus, the invention provides a cluster composition and a pharmaceutical composition, for use in delivery and preparation for administration of antimicrobial agents and treatment of infections.

Abstract: The present invention relates to ultrasound mediated delivery of therapeutic agents to the pancreas, and particularly for treatment of pancreatic cancer such as pancreatic ductal adenocarcinoma (PDAC). More particularly, the invention provides a cluster composition and a pharmaceutical composition, for use in delivery of therapeutic agents and for treatment of pancreatic cancers, including PDAC.

Abstract: A staking terminal includes a conductor portion having a conductor platform, a first plurality of tines extending from the conductor platform, and a conductor crimp extending from the conductor platform. The conductor platform and the tines are not coplanar in a folded configuration. The staking terminal further includes a ground portion having a ground platform, a second plurality of tines extending from the ground platform, and a first braid crimp extending from the ground platform. The ground platform and the tines are not coplanar in the folded configuration.

Abstract: A lane departure warning system is configured to be securely coupled to a portion of a vehicle. The lane departure warning system includes a bracket that is configured to securely retain a camera assembly, and a securing adhesive pad attachable to the bracket. The securing adhesive pad includes a substrate, a first adhesive layer on a first side of the substrate that is configured to secure the securing adhesive pad to the bracket, and a second adhesive layer on a second side of the substrate that is configured to secure the lane departure warning system to the vehicle.

Abstract: The present invention relates to ultrasound (US) mediated delivery of therapeutic agents, such as the delivery of a drug, gene, nanoparticle or radioisotope, using a bi-phasic microparticle system comprising gas microbubbles, emulsion microdroplets and clusters thereof. Thus, the present invention relates to a cluster composition and a pharmaceutical composition, and their use for delivery of therapeutic agents and as a contrast agent for ultrasound imaging. It further relates to methods for delivering such therapeutic agents and to the use of said compositions.

Abstract: A lane departure warning system is configured to be securely coupled to a portion of a vehicle. The lane departure warning system includes a bracket that is configured to securely retain a camera assembly, and a securing adhesive pad attachable to the bracket. The securing adhesive pad includes a substrate, a first adhesive layer on a first side of the substrate that is configured to secure the securing adhesive pad to the bracket, and a second adhesive layer on a second side of the substrate that is configured to secure the lane departure warning system to the vehicle.

Abstract: A staking terminal includes a conductor portion having a conductor platform, a first plurality of tines extending from the conductor platform, and a conductor crimp extending from the conductor platform. The conductor platform and the tines are not coplanar in a folded configuration. The staking terminal further includes a ground portion having a ground platform, a second plurality of tines extending from the ground platform, and a first braid crimp extending from the ground platform. The ground platform and the tines are not coplanar in the folded configuration.

Abstract: A method of and apparatus for fluffing a cleaning article. The cleaning article has a layer of tow fibers and a layer of sheet material, joined together in a layered construction. The apparatus and process spray a fluid blast onto the article, disrupting the tow fibers. The fluid may be air and causes different fibers to react so as to increase the volume of the cleaning article.

Abstract: Disclosed is an ultrasound (US) mediated delivery of therapeutic agents, such as the delivery of a drug, gene, nanoparticle or radioisotope, using a bi-phasic microparticle system including gas microbubbles, emulsion microdroplets and clusters thereof. Also, disclosed are a cluster composition and a pharmaceutical composition, and their use for delivery of therapeutic agents and as a contrast agent for ultrasound imaging. Moreover, disclosed are a method for delivering such therapeutic agents and the use of said compositions.

Abstract: Apparatuses and methods for producing an absorbent article are provided. Generally, the apparatuses and methods allow for continuous delivering of a plurality of web material to downstream equipment during a manufacturing process. In some embodiments, the apparatuses and methods allow for simultaneously unwinding, splicing, and lamination of multiple rolls of web material rotatably mounted to a frame and delivering the web material to various downstream manufacturing processes.

Abstract: A method of and apparatus for fluffing a cleaning article. The cleaning article has a layer of tow fibers and a layer of sheet material, joined together in a layered construction. The apparatus and process spray a fluid blast onto the article, disrupting the tow fibers. The fluid may be air and causes different fibers to react so as to increase the volume of the cleaning article.

Abstract: A method is provided including obtaining ultrasound information including anatomy information representative of a portion of anatomy to be imaged and artifact information representative of a coherent interference artifact. A contrast agent has been associated with the coherent interference artifact. Due to association with the contrast agent, the coherent interference artifact appears in different realizations in a plurality of readings taking along a single line. The method also includes suppressing the artifact information to form revised ultrasound information. Suppressing the artifact information includes using the plurality of readings to suppress the artifact information. Also, the method includes reconstructing the ultrasound image using the revised ultrasound information.

Abstract: A method for using a connector with terminals for connecting to a circuit card. The connector includes a socket having a casing with an aperture for receiving the circuit card therein and electrically conductive terminals. The terminals include an elongated portion and a substantially L-shaped portion joined together by a U-shaped portion. The elongated portion has a proximal end and a distal end, and includes a support section and a bending section between the proximal end and the distal end. The U-shaped portion is disposed at the distal end of the elongated portion. The terminal continues from the U-shaped portion to approximately halfway towards the proximal end of the elongated portion and turns away from the elongated portion thereby forming the substantially L-shaped portion. The L-shaped portion ends in a lip section curving towards the proximal end of the elongated portion.